Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/36713| Title: | Patients With Atrial Fibrillation and PCI or ACS Does Predicted Risk Matter? | Authors: | VRANCKX, Pascal Angiolillo, Dominick J. Valgimigli, Marco |
Issue Date: | 2022 | Publisher: | ELSEVIER SCIENCE INC | Source: | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 79 (5) , p. 428 -431 | Notes: | Vranckx, P (corresponding author), Jessa Ziekenhuis, Hartctr Hasselt, Stadsomvaart 11, B-3500 Hasselt, Belgium. Pascal.Vranckx@jessazh.be |
Keywords: | antithrombotic therapy;apixaban;atrial fibrillation;bleeding;risk scores;stroke | Document URI: | http://hdl.handle.net/1942/36713 | ISSN: | 0735-1097 | e-ISSN: | 1558-3597 | DOI: | 10.1016/j.jacc.2021.11.034 | ISI #: | WOS:000749861200003 | Rights: | 2022 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION PUBLISHED BY ELSEVIER Free access | Category: | A2 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Patients With Atrial Fibrillation and PCI or ACS.pdf | Published version | 152.92 kB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
1
checked on May 8, 2024
Page view(s)
28
checked on Jul 20, 2022
Download(s)
2
checked on Jul 20, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.